Global Laryngeal Cancer Therapeutics Market 2019-2023 | Advent of Novel Therapies to Boost Growth | Technavio
LONDON--(BUSINESS WIRE)--May 3, 2019--The global laryngeal cancer therapeutics market is expected to post a CAGR of over 7% during the period 2019-2023, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190503005297/en/
Technavio has published a new market research report on the global laryngeal cancer therapeutics market from 2019-2023. (Graphic: Business Wire)
The increasing use of tobacco products is the major factor for the rising incidence of laryngeal cancer. The highest incidence of laryngeal cancer is found among African-Americans, followed by Caucasians, in the country. The strong mortality rate and the prevalence of the indication are leading to an increase in the use of therapeutics such as chemotherapy and targeted therapy for the treatment. Also, factors such as the increasing incidence of HPV-caused cancers are driving the growth of the market because of the metastatic nature of the virus. Hence, the global laryngeal cancer therapeutics market is expected to benefit from the increasing prevalence of the indication during the forecast period.
As per Technavio, the advent of novel therapies will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global laryngeal cancer therapeutics market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global laryngeal cancer therapeutics market: Advent of novel therapies
For a long time, the global laryngeal cancer therapeutics market had chemotherapy as the only treatment option. However, the increasing prevalence of the disease and the high mortality rate have resulted in the need for more advanced therapies for the treatment of the disease. As a result, the market has witnessed an increase in the research of novel therapeutics such as targeted therapies, biologics, and regenerative therapies for laryngeal cancer. For instance, gene therapy is a type of novel therapy that is being studied intensively in the early stages of the clinical trials. It involves editing/modifying a gene in the laboratory and inserting it in the patient. The modified gene helps in silencing the faulty gene or modifying the mutated gene in the body, resulting in reversing the damage caused by the indication. Advancements in the research of these novel therapies are expected to add significant value to the growth of the global laryngeal cancer therapeutics market in the coming years.
“Apart from the advent of novel therapies, the increasing number of reimbursement programs, the growing number of strategic alliances, and the increasing research grants are some major aspects that are expected to boost the growth of the global market during the forecast period,” says an analyst at Technavio.
Global laryngeal cancer therapeutics market: Segmentation analysis
This market research report segments the global laryngeal cancer therapeutics market by type (biologics and small molecules) and geographical regions (North America, Europe, Asia, ROW).
The North American region led the market in 2018, followed by Europe, Asia, and ROW respectively. During the forecast period, the North American region is expected to continue dominating the global market as well as register the highest incremental growth due to the increasing preference for the treatment using therapeutics for various head and neck cancer, including laryngeal cancer.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190503005297/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 05/03/2019 11:20 AM/DISC: 05/03/2019 11:20 AM